Alphamab Oncology (9966.HK)

HKD 7.85

(21.52%)

Net Debt Summary of Alphamab Oncology

Alphamab Oncology's latest annual net debt in 2023 was -828.9 Million CNY , down -14.52% from previous year.
Alphamab Oncology's latest quarterly net debt in 2024 Q2 was -820.19 Million CNY , down 0.0% from previous quarter.
Alphamab Oncology reported annual net debt of -723.79 Million CNY in 2022, down -335.93% from previous year.
Alphamab Oncology reported annual net debt of -166.03 Million CNY in 2021, down -542.95% from previous year.
Alphamab Oncology reported quarterly net debt of -828.9 Million CNY for 2023 Q4, down 0.0% from previous quarter.
Alphamab Oncology reported quarterly net debt of -828.9 Million CNY for 2023 FY, down -14.52% from previous quarter.

Annual Net Debt Chart of Alphamab Oncology (2023 - 2017)

Historical Annual Net Debt of Alphamab Oncology (2023 - 2017)

Year	Net Debt	Net Debt Growth
2023	-828.9 Million CNY	-14.52%
2022	-723.79 Million CNY	-335.93%
2021	-166.03 Million CNY	-542.95%
2020	37.48 Million CNY	102.32%
2019	-1.61 Billion CNY	-208.92%
2018	-522.69 Million CNY	-26890.98%
2017	1.95 Million CNY	0.0%

Year	Net Debt	Net Debt Growth
2024 Q2	-820.19 Million CNY	0.0%
2023 Q4	-828.9 Million CNY	0.0%
2023 FY	-828.9 Million CNY	-14.52%
2023 Q2	-852.71 Million CNY	0.0%
2022 Q2	-451.27 Million CNY	0.0%
2022 FY	-723.79 Million CNY	-335.93%
2022 Q4	-723.79 Million CNY	0.0%
2021 Q2	-388.82 Million CNY	0.0%
2021 Q4	-166.03 Million CNY	0.0%
2021 FY	-166.03 Million CNY	-542.95%
2020 Q2	9.46 Million CNY	0.0%
2020 FY	37.48 Million CNY	102.32%
2020 Q4	37.48 Million CNY	0.0%
2019 FY	-1.61 Billion CNY	-208.92%
2019 Q4	-1.61 Billion CNY	0.0%
2019 Q2	-77.18 Million CNY	0.0%
2018 Q4	-522.69 Million CNY	0.0%
2018 FY	-522.69 Million CNY	-26890.98%
2017 FY	1.95 Million CNY	0.0%

Peer Net Debt Comparison of Alphamab Oncology

Name	Net Debt	Net Debt Difference
Uni-Bio Science Group Limited	-76.36 Million HKD	-985.399%
CK Life Sciences Int'l., (Holdings) Inc.	5.26 Billion HKD	115.738%